These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24106768)
1. Associations of novel adipocytokines with bone biomarkers in intra uterine growth-restricted fetuses/neonates at term. Briana DD; Boutsikou M; Boutsikou T; Malamitsi-Puchner A J Matern Fetal Neonatal Med; 2014 Jul; 27(10):984-8. PubMed ID: 24106768 [TBL] [Abstract][Full Text] [Related]
2. Relationships between maternal novel adipocytokines and bone biomarkers in complicated by gestational hypertensive disorders and normal pregnancies. Briana DD; Boutsikou M; Boutsikou T; Malamitsi-Puchner A J Matern Fetal Neonatal Med; 2013 Aug; 26(12):1219-22. PubMed ID: 23406471 [TBL] [Abstract][Full Text] [Related]
3. Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction. Briana DD; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D; Vraila VM; Creatsas G; Malamitsi-Puchner A Bone; 2008 Feb; 42(2):307-13. PubMed ID: 18024242 [TBL] [Abstract][Full Text] [Related]
4. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction. Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A Neonatology; 2009; 96(2):132-6. PubMed ID: 19365143 [TBL] [Abstract][Full Text] [Related]
5. Intrauterine growth restriction may not suppress bone formation at term, as indicated by circulating concentrations of undercarboxylated osteocalcin and Dickkopf-1. Briana DD; Gourgiotis D; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A Metabolism; 2012 Mar; 61(3):335-40. PubMed ID: 21944272 [TBL] [Abstract][Full Text] [Related]
7. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth. Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Hassiakos D; Malamitsi-Puchner A Neonatology; 2008; 93(3):153-7. PubMed ID: 17878741 [TBL] [Abstract][Full Text] [Related]
8. Effect of intrauterine growth pattern on serum visfatin concentrations in full-term infants at birth and at 6 months of life. El Shemi MS; Mohamed MH; AbdelRahman AO; Abdel Al H; Ramadan NM J Neonatal Perinatal Med; 2016; 9(1):73-82. PubMed ID: 27002258 [TBL] [Abstract][Full Text] [Related]
9. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women. Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438 [TBL] [Abstract][Full Text] [Related]
10. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Liosi S; Hassiakos D; Malamitsi-Puchner A Metabolism; 2011 Apr; 60(4):486-90. PubMed ID: 20488498 [TBL] [Abstract][Full Text] [Related]
11. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth. Briana DD; Boutsikou M; Gourgiotis D; Boutsikou T; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A J Matern Fetal Neonatal Med; 2008 Nov; 21(11):826-30. PubMed ID: 19031279 [TBL] [Abstract][Full Text] [Related]
12. Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women. Zhang H; Xie H; Zhao Q; Xie GQ; Wu XP; Liao EY; Luo XH J Endocrinol Invest; 2010 Nov; 33(10):707-11. PubMed ID: 20208458 [TBL] [Abstract][Full Text] [Related]
13. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus. Oncul M; Tuten A; Erman H; Gelisgen R; Benian A; Uzun H Minerva Med; 2013 Oct; 104(5):527-35. PubMed ID: 24101110 [TBL] [Abstract][Full Text] [Related]
14. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction. Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243 [TBL] [Abstract][Full Text] [Related]
15. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Peng XD; Xie H; Zhao Q; Wu XP; Sun ZQ; Liao EY Clin Chim Acta; 2008 Jan; 387(1-2):31-5. PubMed ID: 17884030 [TBL] [Abstract][Full Text] [Related]
16. Serum cystatin C in pregnancies with normal and restricted fetal growth. Malamitsi-Puchner A; Briana DD; Kontara L; Boutsikou M; Baka S; Hassiakos D; Marmarinos A; Gourgiotis D Reprod Sci; 2007 Jan; 14(1):37-42. PubMed ID: 17636214 [TBL] [Abstract][Full Text] [Related]
18. The effect of intrauterine growth restriction on circulating surfactant protein D concentrations in the perinatal period. Briana DD; Gourgiotis D; Baka S; Boutsikou M; Vraila VM; Boutsikou T; Hassiakos D; Malamitsi-Puchner A Reprod Sci; 2010 Jul; 17(7):653-8. PubMed ID: 20360592 [TBL] [Abstract][Full Text] [Related]
19. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. Boutsikou T; Malamitsi-Puchner A; Economou E; Boutsikou M; Puchner KP; Hassiakos D Early Hum Dev; 2006 Apr; 82(4):235-9. PubMed ID: 16337100 [TBL] [Abstract][Full Text] [Related]
20. Puerarin affects bone biomarkers in the serum of rats with intrauterine growth restriction. Chen J; Chen P; Qi H; Huang D J Tradit Chin Med; 2016 Apr; 36(2):211-6. PubMed ID: 27400476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]